Endometrial Polyp
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Aged 18-60 years 2: Intravenous general anesthesia for hysteroscopic surgery 3: ASA class I-II 4: Agree to participate in this clinical trial and sign the informed consent form voluntarily
Exclusion criteria
Exclusion criteria: 1: Patients with contraindications to electroacupuncture or electrical stimulation; patients with swelling, infection, or ulceration of the TEAS site 2: Patients with preoperative history of severe cardiovascular and cerebrovascular diseases, abnormalities of liver and kidney function, endocrine disorders 3: Patients on chronic psychotropic drugs or abusing alcohol or prohibited drugs 4: Inability to self-assess anxiety/pain, unable to cooperate in completing questionnaires 5: Patients previously treated with TEAS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| State-Trait Anxiety Inventory Short Form (STAI-S6) Scoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative day 1 scores (using the VAS scale), postoperative 15-item quality of recovery (QoR-15), and postoperative satisfaction scores;Postoperative day 1 sleep scores (using the VAS scale); postoperative 15-item quality of recovery (QoR-15);postoperative satisfaction scores.;Visual Analog Scale for Anxiety (VAS-A);Hemodynamic changes (Mean Arterial Pressure, Heart Rate);Amount of propofol used intraoperatively; | — |
Countries
china
Contacts
Beijing University of Chinese Medicine Shenzhen Hospital (Longgang)